SCHEDULE 13G
Statement of Beneficial Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0002163771-26-000002
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Baggett Benjamin Matthew Wall | 300,000 | 7.3% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…